Prostate Cancer - Results from #1200

Assessing Response to PSMA Radiopharmaceutical Therapies with Single SPECT Imaging at 24 Hours After Injection. May 13, 2024

Applications of wearable activity monitors for prostate cancer survivors: A systematic scoping review. May 13, 2024

Perioperative, Oncological and Functional Outcomes Between Robot-Assisted Laparoscopic Prostatectomy and Open Radical Retropubic Prostatectomy: A Randomized Clinical Trial. May 13, 2024

Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer. May 13, 2024

Incidental prostate cancer after holmium laser enucleation of the prostate: Critical analysis of independent risk factors and impact on surgical outcomes. May 13, 2024

Defining oligometastatic state in uro-oncological cancers. May 10, 2024

Prostate Cancer Incidence and Mortality in Men Exposed to α1-Adrenoceptor Antagonists. May 10, 2024

A Model for Predicting Clinically Significant Prostate Cancer using Prostate MRI and Risk Factors. May 10, 2024

The association between neighborhood obesogenic factors and prostate cancer risk and mortality: the Southern Community Cohort Study. May 10, 2024

Prostate biopsy sepsis prevention: external validation of an alcohol needle washing protocol. May 10, 2024

A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer. May 10, 2024

Salivary excretion of systemically injected [18F]DCFPyL in prostate cancer patients undergoing PSMA scans. May 9, 2024

Baseline serum testosterone and differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trial. May 9, 2024

Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN. May 9, 2024

Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) Score as a Predictive Value of Incidental Prostate Cancer for Patients Going for Transurethral Resection of the Prostate (TURP): A Single-Center Study. May 9, 2024

Active surveillance of low-grade prostate cancer using the SurACaP Criteria: A multi-institutional series with a median follow-up of 10years. May 9, 2024

The additional value of 68Ga-PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsy. May 8, 2024

Comparison of quantitative whole body PET parameters on [68Ga]Ga-PSMA-11 PET/CT using ordered Subset Expectation Maximization (OSEM) vs. bayesian penalized likelihood (BPL) reconstruction algorithms in men with metastatic castration-resistant prostate can May 8, 2024

Clinically Significant Prostate Cancer Detection Following Transrectal and Transperineal Biopsy: Results of the Prostate Biopsy Efficacy and Complications Randomized Clinical Trial. May 8, 2024

Prostate-specific Membrane Antigen: Diagnostics. May 8, 2024

Page 61 of 1450